Study Of Diabetic Nephropathy With Atrasentan

NCT01858532 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

5107

Enrollment

INDUSTRY

Sponsor class

Stopped Strategic considerations

Conditions

Diabetic Nephropathy

Interventions

DRUG: Atrasentan
DRUG: Placebo

Sponsor

AbbVie